You are here: Industry Insights > LDL

News List

Women Should Take These 3 Things to Heart drugs.com
February 12, 2022
February is American Heart Month — the perfect time to remind women of three things they need to know about heart disease.
CVD Risk Up in Later Life for Young Adults With High LDL or Hypertension drugs
July 17, 2019
CVD Risk Up in Later Life for Young Adults With High LDL or Hypertension.
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease drugs
June 03, 2019
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease.
High LDL Cholesterol Tied to Early-Onset Alzheimer's drugs
May 30, 2019
High LDL Cholesterol Tied to Early-Onset Alzheimer's.
Adding Bempedoic Acid to Statin Therapy Reduces LDL Cholesterol drugs
March 14, 2019
Bempedoic acid, an inhibitor of ATP citrate lyase (ACLY), added to maximally tolerated statin therapy, significantly reduces levels of low-density lipoprotein (LDL) cholesterol in patients with atherosclerotic cardiovascular disease and/or heterozygous fa
Esperion's LDL drug aces a third pivotal trial fiercebiotech
May 29, 2018
In its third pivotal trial readout this year, the 180-mg dose of Esperion's LDL cholesterol-lowering treatment, bempedoic acid, hit its primary endpoint in a trial of high-risk patients with atherosclerotic cardiovascular disease (ASCVD).
Esperion’s phase 3 LDL study raises flags with treatment-arm deaths fiercebiotech
May 03, 2018
Esperion unveiled top-line results from a yearlong phase 3 trial of bempedoic acid, showing it can lower LDL cholesterol levels by an additional 20% over 12 weeks in high-risk patients taking statins.
Esperion hits goal in LDL trial, pulls forward NDA target date fiercebiotech
August 10, 2017
The data bolster Esperion's hand as it gets deeper into talks about partnerships